(Q39850437)

English

Evaluation of the in vitro bactericidal action of ciprofloxacin on cells of Escherichia coli in the logarithmic and stationary phases of growth

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 September 2017

Evaluation of the in vitro bactericidal action of ciprofloxacin on cells of Escherichia coli in the logarithmic and stationary phases of growth (English)

1 reference

Europe PubMed Central

15 September 2017

Escherichia coli

0 references

author name string

Zeiler HJ

1

1 reference

Europe PubMed Central

15 September 2017

language of work or name

0 references

publication date

1 October 1985

1 reference

Europe PubMed Central

15 September 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

15 September 2017

28

1 reference

Europe PubMed Central

15 September 2017

524-527

1 reference

Europe PubMed Central

15 September 2017

4

1 reference

Europe PubMed Central

15 September 2017

Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180297

22 September 2017

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180297

22 September 2017

In vitro activity of ciprofloxacin (Bay o 9867)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180297

22 September 2017

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180297

22 September 2017

Investigations into the mechanism of action of the antibacterial agent norfloxacin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180297

22 September 2017

Escherichia coli K-12 Mutants Resistant to Nalidixic Acid: Genetic Mapping and Dominance Studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180297

22 September 2017

The in vitro and in vivo activity of ciprofloxacin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180297

15 June 2018

In-vitro studies with ciprofloxacin, a new 4-quinolone compound.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180297

15 June 2018

In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/2934022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.28.4.524

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39850437&oldid=2091487141"